New Research: 2 stocks to buy as Nifty50 heads towards 40,000
Here is the latest financial fact sheet of DR. LAL PATHLABS. For more details, see the DR. LAL PATHLABS quarterly results and DR. LAL PATHLABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.3 |
No. of shares | m | 83.48 |
1 Week | % | 14.4 |
1 Month | % | -5.0 |
1 Year | % | 25.8 |
52 week H/L | Rs | 2,766.9/1,790.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DR. LAL PATHLABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,120 | 1,846 | 2,735 | 4,243 | 2,870 | |
Low | Rs | 800 | 950 | 1,305 | 2,266 | 1,763 | |
Sales per share (Unadj.) | Rs | 144.4 | 159.6 | 189.7 | 250.5 | 241.9 | |
Earnings per share (Unadj.) | Rs | 24.1 | 27.3 | 35.6 | 42.0 | 28.9 | |
Diluted earnings per share | Rs | 24.0 | 27.3 | 35.5 | 42.0 | 28.9 | |
Cash flow per share (Unadj.) | Rs | 28.6 | 36.0 | 44.8 | 55.0 | 46.9 | |
Dividends per share (Unadj.) | Rs | 6.00 | 12.00 | 20.00 | 12.00 | 12.00 | |
Adj. dividends per share | Rs | 5.99 | 11.98 | 19.97 | 11.98 | 11.98 | |
Avg Dividend yield | % | 0.6 | 0.9 | 1.0 | 0.4 | 0.5 | |
Book value per share (Unadj.) | Rs | 110.1 | 120.0 | 144.6 | 173.2 | 192.9 | |
Adj. book value per share | Rs | 109.9 | 119.8 | 144.4 | 172.9 | 192.6 | |
Shares outstanding (eoy) | m | 83.34 | 83.34 | 83.34 | 83.34 | 83.37 | |
Price / Sales ratio | x | 6.6 | 8.8 | 10.6 | 13.0 | 9.6 | |
Avg P/E ratio | x | 39.9 | 51.2 | 56.8 | 77.4 | 80.1 | |
P/CF ratio (eoy) | x | 33.5 | 38.8 | 45.1 | 59.2 | 49.4 | |
Price / Book Value ratio | x | 8.7 | 11.7 | 14.0 | 18.8 | 12.0 | |
Dividend payout | % | 24.9 | 43.9 | 56.2 | 28.6 | 41.5 | |
Avg Mkt Cap | Rs m | 80,008 | 116,512 | 168,365 | 271,229 | 193,109 | |
Total wages/salary | Rs m | 2,083 | 2,426 | 2,737 | 3,649 | 3,765 |
DR. LAL PATHLABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 12,034 | 13,304 | 15,813 | 20,874 | 20,169 | |
Other income | Rs m | 459 | 550 | 513 | 525 | 417 | |
Total revenues | Rs m | 12,494 | 13,854 | 16,326 | 21,400 | 20,586 | |
Gross profit | Rs m | 2,937 | 3,436 | 4,363 | 5,607 | 4,898 | |
Depreciation | Rs m | 382 | 728 | 772 | 1,081 | 1,502 | |
Interest | Rs m | 8 | 153 | 160 | 302 | 375 | |
Profit before tax | Rs m | 3,005 | 3,105 | 3,944 | 4,750 | 3,438 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,001 | 829 | 979 | 1,247 | 1,028 | |
Profit after tax | Rs m | 2,005 | 2,276 | 2,965 | 3,503 | 2,411 | |
Gross profit margin | % | 24.4 | 25.8 | 27.6 | 26.9 | 24.3 | |
Effective tax rate | % | 33.3 | 26.7 | 24.8 | 26.3 | 29.9 | |
Net profit margin | % | 16.7 | 17.1 | 18.7 | 16.8 | 12.0 |
DR. LAL PATHLABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,136 | 8,926 | 11,452 | 8,752 | 9,731 | |
Current liabilities | Rs m | 1,383 | 2,273 | 2,743 | 5,000 | 4,698 | |
Net working cap to sales | % | 56.1 | 50.0 | 55.1 | 18.0 | 25.0 | |
Current ratio | x | 5.9 | 3.9 | 4.2 | 1.8 | 2.1 | |
Inventory Days | Days | 69 | 55 | 21 | 20 | 38 | |
Debtors Days | Days | 16 | 14 | 15 | 15 | 13 | |
Net fixed assets | Rs m | 2,554 | 4,588 | 4,881 | 14,346 | 13,721 | |
Share capital | Rs m | 833 | 833 | 833 | 833 | 834 | |
"Free" reserves | Rs m | 8,341 | 9,166 | 11,219 | 13,600 | 15,247 | |
Net worth | Rs m | 9,175 | 9,999 | 12,053 | 14,433 | 16,080 | |
Long term debt | Rs m | 0 | 0 | 1 | 1,668 | 833 | |
Total assets | Rs m | 10,690 | 13,515 | 16,333 | 23,097 | 23,451 | |
Interest coverage | x | 359.2 | 21.3 | 25.6 | 16.7 | 10.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.1 | 1.0 | 1.0 | 0.9 | 0.9 | |
Return on assets | % | 18.8 | 18.0 | 19.1 | 16.5 | 11.9 | |
Return on equity | % | 21.9 | 22.8 | 24.6 | 24.3 | 15.0 | |
Return on capital | % | 32.9 | 32.6 | 34.0 | 31.4 | 22.5 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0.7 | 0.6 | 0.7 | 0.5 | 0.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 88 | 86 | 105 | 98 | 101 | |
Fx inflow | Rs m | 155 | 177 | 143 | 188 | 220 | |
Fx outflow | Rs m | 88 | 86 | 105 | 98 | 101 | |
Net fx | Rs m | 67 | 91 | 38 | 90 | 119 |
DR. LAL PATHLABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,185 | 2,839 | 3,982 | 4,467 | 4,560 | |
From Investments | Rs m | -997 | -261 | -2,120 | -4,492 | -2,873 | |
From Financial Activity | Rs m | -553 | -1,904 | -1,386 | 1,365 | -2,832 | |
Net Cashflow | Rs m | 635 | 673 | 476 | 1,339 | -1,145 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Arvind Lal | COMP SEC: Rajat Kalra | YEAR OF INC: 1995 | BSE CODE: 539524 | FV (Rs): 10 | DIV YIELD (%): 0.5 |
Read: DR. LAL PATHLABS 2022-23 Annual Report Analysis
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare DR. LAL PATHLABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.